Akzo Nobel NV AKZO NOBEL ORD SHS/ NL0013267909 /
| 2024-05-24 6:18:03 PM | Chg. - | Volume | Bid5:40:09 PM | Ask5:40:09 PM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 64.46EUR | - | 634,519 Turnover: 1.65 mill. |
-Bid Size: - | -Ask Size: - | 10.85 bill.EUR | 3.11% | 24.27 |
GlobeNewswire
05-29
Intra-Cellular Therapies to Present at the Jefferies Global Healthcare Conference
GlobeNewswire
05-28
VITAL VOICES HONORS WOMEN LEADING THE RISE AT 3RD ANNUAL FESTIVAL & 23RD ANNUAL GLOBAL LEADERSHIP AW...
GlobeNewswire
05-21
CancerVax Successfully Uses Nobel Prize Chemistry to Achieve Universal Cancer Vaccine Targeting Mile...
GlobeNewswire
05-15
Study Shows High Volume Exercise Unrelated to Progression of Coronary Artery Calcium
GlobeNewswire
05-13
Lycia Therapeutics Completes $106.6 Million Series C Financing to Advance Pipeline of LYTAC Extracel...
GlobeNewswire
05-09
CRISPR Therapeutics to Present at the Bank of America Securities Health Care Conference
GlobeNewswire
05-01
Enrollment Completed in Phase 2a Study with Cocrystal Pharma’s Oral Antiviral Candidate CC-42344 for...
GlobeNewswire
04-30
Intra-Cellular Therapies to Host First Quarter 2024 Financial Results Conference Call and Webcast
GlobeNewswire
04-25
Regeneron and Mammoth Biosciences Collaborate to Pursue Next-Generation CRISPR-Based Gene Editing fo...
GlobeNewswire
04-24
Intra-Cellular Therapies Announces Closing of $575 Million Public Offering Including Full Exercise o...
Newsfile Corp
04-24
Peter Nobel Descendant of Nobel Family Shares the Mission and Vision of Nobel Sustainability Trust a...
GlobeNewswire
04-22
Clover Health Appoints Healthcare Technology Veteran Peter Kuipers as Chief Financial Officer
GlobeNewswire
04-16
Telomir Pharmaceuticals Unveils Compelling Pre-clinical Data on Age-Reversal Drug Telomir-1 at Natio...
GlobeNewswire
04-13
C.K. McWhorter Endows Wimbledon Championships With Esteemed McWhorter Family Trust Warrant Of Excell...
